$2.21 +0.11 (5.19%)

ECARX Holdings Inc. Class A Ordinary shares (ECX)

ECARX Holdings Inc. is a technology company specializing in automotive intelligent cockpit solutions and connected vehicle systems. It develops advanced electronic architecture, AI-powered cockpit controls, and infotainment systems aimed at enhancing vehicle connectivity, safety, and user experience. The company's offerings are primarily targeted at automakers seeking to integrate innovative digital technologies into their vehicles.

🚫 ECARX Holdings Inc. Class A Ordinary shares does not pay dividends

Company News

ECARX Powers Launch of Lynk & Co 10 EM-P, Integrating Pikes® Computing Platform
GlobeNewswire Inc. • Ziyu Shen • September 8, 2025

ECARX announced the launch of Lynk & Co 10 EM-P plug-in hybrid sedan, featuring its Pikes® computing platform and Cloudpeak® software stack, powered by Qualcomm's Snapdragon SA8295P automotive-grade SoC.

ECARX Reports $156 Million Q2 Revenue
The Motley Fool • Motley Fool Markets Team • August 26, 2025

ECARX reported Q2 2025 earnings with $156 million revenue, shipping 532,000 units. The company achieved a 20% reduction in operating expenses, secured over $1 billion in overseas contracts, and is diversifying its revenue streams beyond automotive through LiDAR technology.

Can ECARX Sustain Its Revaluation on SaaS Momentum and Platform Leverage?
Investing.com • Timothy Fries • July 3, 2025

ECARX is making significant strides in automotive software integration, dramatically reducing Google Automotive Services certification timelines and positioning itself as a key enabler of software-defined vehicles through strategic partnerships and innovative technology platforms.

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Lisa Levin • September 13, 2023

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) gained 63.5% to $0.2101. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) rose 31.8% to $20.15 after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 22.2% to $0.1090. Axcella Health Inc. (NASDAQ: AXLA) shares jumped 19.3% to $1.36 after jumping more than 59% on Tuesday. Alset Capital Acquisition Corp. (NASDAQ: ACAX) gained 19.1% to $10.60. Ohmyhome Limited (NASDAQ: OMH) gained 18.2% to $1.9147. ECARX Holdings Inc. (NASDAQ: ECX) surged 16.8% to $3.5628. VEON Ltd. (NASDAQ: VEON) gained 16.4% to $19.30. Super League Enterprise, Inc. (NASDAQ: SLE) shares gained 16.2% to $2.2650 after falling 40% on Tuesday. DZS Inc. (NASDAQ: DZSI) gained 15.3% to $2.11. DZS secured $29.7 million in financing. HireRight Holdings Corporation (NYSE: HRT) climbed 14.8% to $10.05. HireRight plans additional $25 million share repurchase program. Sigma Lithium Corporation (NASDAQ: SGML) rose 13.7% to $36.54. Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) gained 13.3% to $0.1050. Workhorse Group Inc. (NASDAQ: WKHS) shares rose 13.2% to $0.7199 ...